AmeriPharma’s premier pharmacy services are available in multiple states throughout the US.
Mon - Fri: 9:00AM - 10:00PM Sat - Sun: Closed

Related Posts

Welcome to Infusion Center

Get Financial Relief Now

Apply for Reblozyl Copay Assistance

Free service matches you with top copay assistance programs

Specialists assist you throughout the application process

Get automated updates on your funding status

Over $55 million secured for our patients to date

How Much Can You Save?

Speak With a Copay Assistance Specialist

We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances.

Medi-Cal logo
LegitScript approved

Get Started in Minutes

How Reblozyl Copay Assistance Works

plus icon with transparent background

1 – Check Your Coverage/Benefits Verification

Our team of expert billers finds the best avenues of coverage that minimize out-of-pocket costs.

Rx icon

2 – Transfer Prescription to AmeriPharma

We process your prescription by working with your previous pharmacy or prescriber, making the transition quick and easy.

document icon with transparent background

3 – Prior Authorization

Our team of specialists obtains approval from your insurance companies within 24 to 72 hours.

document and personnel icon with transparent background

4 – Copay Assistance & Financial Aid

We secure financial aid and decrease copays, out-of-pocket expenses, and high deductibles. To date, AmeriPharma Specialty Care has secured $55 million in financial assistance for our patients.

3 hands and plus icon with transparent background

5 – Nursing Care Coordination

AmeriPharma puts your schedule and home environment first when scheduling and coordinating one of our specialized nurses for your in-home infusions.

box icon with transparent background

6 – Delivery Coordination

Medications are always delivered in strict compliance with the specific requirements for immune globulin shipping. Next-day and overnight cold-chain deliveries are coordinated around your schedule.

Speak With a Specialist

We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.

What Is Reblozyl?

Reblozyl, also known by its generic name “luspatercept,” is a prescription drug used to treat symptoms of anemia (low red blood cell counts) in adult patients suffering from blood disorders such as myelodysplastic syndrome (MDS) and beta-thalassemia. 

Reblozyl belongs to the drug class of “erythroid maturation agents” (EMA) that works to improve the erythropoiesis process (a process involved in the production of mature red blood cells). In other words, it works by creating more mature, working red blood cells (RBCs) and allows immature cells to mature and work the correct way. This improves the quality of RBCs and increases the amount of hemoglobin (Hgb) in the body, resulting in the improvement of anemia because there are more mature RBCs in the bloodstream. Reblozyl is the only drug of this class that is FDA-approved for treating anemia in adult patients who require regular red blood cell (RBC) transfusions or whose anemia does not respond well to other erythroid maturation agents. 

Reblozyl can only be obtained through a doctor’s prescription and is available in single-dose vials for injection purposes in two different strengths: 25 mg and 75 mg.

Schedule a Consultation

We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.

What Is Reblozyl Used To Treat?

Reblozyl has been approved as a first-class therapy to treat anemia associated with the following blood disorders in adults:

  • Beta thalassemia – a rare type of inherited blood disorder in which patients either have missing or defective genes that make beta globin protein. This protein is a component of hemoglobin protein present in RBCs which carries oxygen around the body. When you have thalassemia, your body is making less hemoglobin than normal, and it can result in mild or severe anemia. When hemoglobin levels are low, it can cause muscle weakness, fatigue, and many more serious complications. Reblozyl is indicated in adult patients with beta thalassemia who require regular RBC transfusions.
  • Myelodysplastic syndrome (MDS) – a group of cancers in which immature blood-forming cells in the bone marrow do not develop (mature) or become healthy functional cells. The most common cells affected by MDS are red blood cells. When immature cells do not work the way that they should, this leaves less room for healthy white blood cells (WBCs), RBCs, and platelets to form in the bone marrow. Anemia, infection, or easy bleeding can occur as a result of fewer healthy blood cells.

Copay and Financial Assistance

AmeriPharma Specialty Care alleviates financial burdens for patients and their families

Advanced software icon
Advanced software locates funding sources to match you with top-dollar foundation programs
Copay assistance icon
One of our copay assistance specialists will assist with the application process
Funding status icon
Automatic updates will be sent to you and your physician on the status of the funding

Speak With a Specialist

We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.

Reblozyl Side Effects

The most common side effects of Reblozyl include: 

  • Feeling tired
  • Muscle or bone pain
  • Dizziness
  • Diarrhea
  • Stomach (abdominal) pain
  • Allergic reactions
  • Headache
  • Joint pain (arthralgia)
  • Nausea
  • Cough
  • Signs of a common cold
  • Flu-like signs

Some serious side effects that may occur include:

  • Blood clots (thrombosis/thromboembolism)
    • The risk may be greater in people who have had their spleen removed or who take birth control pills or hormone replacement therapy.
    • It is important to call your healthcare provider or get medical help immediately if you experience any of these symptoms:
      • Chest pain
      • Difficulty breathing or shortness of breath
      • Pain in your leg, with or without swelling
      • A pale or cold arm or leg
      • Sudden numbness or weakness that is short-term or continues to occur over an extended period of time, especially if it’s on one side of the body
      • Severe headache or confusion
      • Sudden dizziness or trouble with seeing, walking, speaking, or balancing 
  • High blood pressure (hypertension)
    • Your provider will check your blood pressure before you receive your Reblozyl dose
  • Extramedullary hematopoietic (EMH) masses
    • It is important to call your healthcare provider or get medical help immediately if you experience any of these symptoms:
      • Severe back pain
      • Numbness, weakness, or loss of voluntary movement in the legs, arms, hands, or feet
      • Loss of bowel and bladder control

Schedule a Consultation

We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.

Reblozyl Dosing Information

The dose of Reblozyl is adjusted according to the patient’s body weight, hemoglobin, and transfusion records. The recommended initial dose of Reblozyl is 1 mg/kg once every 3 weeks. 

Dose Modification for B-thalassemia Patients 

The future doses are modified under the following conditions: 

  • If the patient shows insufficient response to the initial dose (1 mg/kg once every 3 weeks) and does not achieve a reduction in RBC transfusions after two treatments ( at least 2 consecutive doses/6 weeks), the dose can be increased to 1.25 mg/kg once every 3 weeks (maximum dose). 
  • Discontinue the treatment if patients show insufficient response to the modified dose (1.25 mg/kg) and do not achieve a reduction in RBC transfusions after three treatments (3 doses/9 weeks). 

Dose Modification for MDS Patients 

The future doses are modified under the following conditions:

  • If the patient shows insufficient response to the initial dose (1 mg/kg) and does not achieve a reduction in RBC transfusions after two treatments (2 doses/6 weeks), then increase the dose to 1.33 mg/kg once every 3 weeks. 
  • If patients show an insufficient response to the modified dose (1.33 mg/kg) and do not achieve a reduction in RBC transfusions after two treatments (2 doses/6 weeks), then increase the dose to 1.75 mg/kg once every 3 weeks. 
  • Discontinue the treatment if patients show an insufficient response to the modified dose (1.75 mg/kg) and do not achieve a reduction in RBC transfusions after three treatments (3 doses/9 weeks).

How Much Can You Save?

Speak With a Copay Assistance Specialist

© 2024 AmeriPharma Specialty Care. All Rights Reserved.  132 S. Anita Dr. 2nd Floor, Orange, CA 92868. Privacy Policy | Terms of use